{"type":"img","src":"//cdn.quv.kr/q86f589vg/up/67e364d9e8d16_1920.png","height":40,"scroll":"//cdn.quv.kr/q86f589vg/up/67e362e6bad68_1920.png"}
  • Home
  • About Us
  • Research
  • Contact
  • Notice
    • {"google":["Montserrat"],"custom":["Noto Sans KR","Hi Melody"]}
    LOGO
    ×
     
     
    섹션 설정
    {"type":"img","src":"https://cdn.quv.kr/q86f589vg%2Fup%2F682d6a4187391_1920.png","height":21}
  • Home
  • About Us
  • Research
  • Contact
  • Notice

    • About Us

    Message from the CEO

     

    HTnB Inc. has been founded with a core vision of conquering the life-threatening diseases and satiating the most dire unmet medical needs. Molded by the innovative spirits and creative minds from Seoul National University (SNU) and Institute of Basic Science (IBS), our team members are second to none in the development of unprecedented nanomedicine and its translation to preclinical breakthroughs.

     

    Since its launch, HTnB Inc. has maintained a robust R&D-driven momentum. We have consolidated the platform technology, streamlined the mass production of our product, and expanded the market opportunities for the genuinely new modality of our breakthrough drugs. 

     

    HTnB strives for nothing but innovation and excellence. We will deliver a safe and efficacious medicine from our bench to your bedside.

     

    Seung Hong Choi MD PhD

    Co-founder & CEO  

    Co-Founder & CEO HTnB Inc.

    Professor Department of Radiology, Seoul National University College of Medicine

     

    Awards & Honors

    KAST Physiology & Medicine Award, The Korean Academy of Science and Technology (2023)  

    Taejoon MedicalAward (2019)

    Yuhan Medical Award (2016)

    Jan. 2022

    Hyeon Tech N Bio Established

    Office 424, Convergence Bldg, Seoul National University College of Medicine

    103, Daehak-ro, Jongno-gu, Seoul, Republic of Korea

    National R&D Grant

    Jun. 2022

    Development of Breakthrough Drugs with Nanoparticle API 

    Jul. 2022

    R&D Center Established

    Bldg 220, Office 630-3, Seoul National University

    1, Gwanak-ro, Gwanak-gu, Seoul, Republic of Korea

    Venture Enterprise Certification

    Mar. 2023

    Venture Enterprise Certification Committee

    Ministry of SMEs and Startups, Republic of Korea

    May. 2023

    R&D Staff Expansion

    Drug Development & Preclinical Development

    Business Development Group (BD)

    Business Strategy & Entry to Global Market

    US National Institute of Allergy & Infectious Diseases (NIAID)

    Armed Forces Radiobiology Research Institute (AFRRI)

    Indication: GI-ARS

     

    Mentor


    Taeghwan Hyeon PhD

    Technological Heritage: Nanotechnology & Application

    Professor Department of Chemical and Biological Engineering, Seoul National University

    Director Center for Nanoparticle Research, Institute of Basic Science (IBS)

    SNU Distinguished Professor

     

    Awards & Honors

    International Member National Academy of Engineering (USA) (2024- )

    International Fellow, Royal Swedish Academy of Engineering Sciences (IVA) (2023- )

    NAEK Grand Prize, The National Academy of Engineering of Korea (2022)

    Clarivate Citation Laureates in Chemistry (2020)

    Presidential Award for Korea's Best Scientist (2016)

    Ho-Am Prize, Samsung Ho-Am Foundation (2012)

    POSCO-TJ Park Award (2008)

    4th DuPont Science and Technology Award (2005)

     

    • Global recognition: synthesis of nanoparticles and application in translational medicine  

    • Mentorship and tech counsel for design and development of drug candidates 

    Heat-up process: mass production of uniform nanocrystals 

    Major breakthrough in large-scale nanocrystal production and industrial applications 


    Eui Kyu Chie MD PhD


    Hak Jae Kim MD PhD

    SNUH Radiation Oncology

    Clinical counsel for radiotherapy & radioprotection

    Auditor Korean Society for Radiation Oncology (2021 - )

    PhD Seoul National University College of Medicine (Radiation Oncology)

    Director Korean Society for Biomedical Laboratory Sciences  (2018 - )

    PhD Seoul National University College of Medicine (Radiation Oncology)


    Sae-Won Han MD PhD

    SNUH Medical Oncology Center

    Post-irradiation alteration microenvironment in tumor and contiguous tissues, and the therapeutic effect of lead candidates

    PhD Seoul National University College of Medicine (Molecular Oncology)


    Jeong-Heum Baek MD PhD

    Gil Medical Center Colorectal Clinic

    Radiotherapy side effect in GI tract, radiation-induced enterocolitis, and their treatment with lead candidates

    President Korean Society of Surgical Oncology
    (2022 - )

    PhD Hanyang University College of Medicine (Surgery)

    Partners




    {"google":["Montserrat"],"custom":["Noto Sans KR","Hi Melody","Nanum Square Round"]}{"google":["Montserrat"],"custom":["Noto Sans KR","Hi Melody","Nanum Square Round"]}

    주식회사 에이치티엔비

     

    대표이사 : 최승홍

    본사 : 서울특별시 종로구 대학로 103,

    서울대학교 의과대학 융합관 424호 (연건동)

    연구소 : 서울특별시 관악구 관악로 1 서울대학교 종합교육연구동

    220동 6층 630-3호 (신림동)

    Tel : +82 2 766  1012 ｜ Fax : +82 2 747 7418

     COPYRIGHT © HTnB Inc. All Rights reserved

    HTnB Inc. 

     

    Chief Executive Officer: Seung Hong Choi

    HQ : 103 Daehak-ro, Jongno-gu, Seoul, Republic of Korea (03080)
    Seoul National University College of Medicine, Convergence Research Building, Office 424

    R&D Center: 1 Gwanak-ro, Gwanak-gu, Seoul, Republic of Korea (08826)
    Seoul National University, Building 220, Office 630-3

    Tel : +82 2 766 1012 ｜ Fax : +82 2 747 7418

     


    COPYRIGHT (C) HTnB Inc. All Rights reserved

    {"google":[],"custom":["Noto Sans KR","Nanum Square Round"]}